— Know what they know.
Not Investment Advice
Also trades as: MEDCL.PA (PAR) · $vol 2M

MDCLF OTC

MedinCell S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +392.7% 1Y: +392.7% 3Y: +254.5%
$34.39
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 48 · $1.2B mcap · 26M float · 0.0000% daily turnover · Short 100% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
20
Balance Sheet
39
Earnings Quality
33
Growth
79
Value
—
Momentum
73
Safety
—
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.90
Unlikely Manipulator
Ohlson O-Score
-2.52
Bankruptcy prob: 7.4%
Low Risk
Credit Rating
BB
Score: 42.0/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.13x
Accruals: -59.5%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDCLF scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDCLF's score of -2.90 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDCLF's implied 7.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDCLF receives an estimated rating of BB (score: 42.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-24.40x
PEG
0.50x
P/S
40.85x
P/B
260.14x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MDCLF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.925
NI / EBT
×
Interest Burden
1.402
EBT / EBIT
×
EBIT Margin
-0.813
EBIT / Rev
×
Asset Turnover
0.652
Rev / Assets
×
Equity Multiplier
-3.840
Assets / Equity
=
ROE
264.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDCLF's ROE of 264.0% is driven by Asset Turnover (0.652), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.92 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1170 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$34.39
Median 1Y
$28.72
5th Pctile
$7.85
95th Pctile
$105.13
Ann. Volatility
79.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE -92.3% 12.3% 2.5% 1.8% 3.4% 3.9% 2.1% 1.4% 1.5% 1.8% 2.6% 2.64%
ROA -12.9% -36.5% -74.6% -1.4% -1.2% -1.0% -1.4% -1.3% -72.6% -82.0% -68.7% -68.75%
ROIC -3.6% -2.9% -4.1% -5.0% -4.9% -3.9% 29.9% 1.0% 88.3% 97.6% 1.2% 1.17%
ROCE -21.6% -41.3% -3.7% -1.9% 86.4% -74.3% -1.4% -1.2% -48.9% -64.4% -44.0% -44.03%
Gross Margin 1.0% 1.3% 85.6% 64.0% 77.0% 58.6% 91.3% 1.0% 1.0% 0.0% 1.0% 1.00%
Operating Margin -2.1% -8.6% -5.8% -2.2% -3.7% -1.5% -3.2% -79.8% -20.6% -78.8% -1.6% -1.58%
Net Margin -1.6% -7.3% -5.2% -2.3% -4.7% -1.2% -4.5% -1.5% -24.0% -1.4% -1.5% -1.52%
EBITDA Margin -2.1% -3.4% -2.2% -82.7% -1.4% -51.7% -3.1% -76.9% -24.5% -70.7% -1.2% -1.17%
FCF Margin -1.6% -2.9% -3.4% -2.8% -3.2% -2.5% -1.7% -13.7% 10.5% 6.9% -17.5% -17.52%
OCF Margin -1.5% -2.7% -3.2% -2.6% -3.0% -2.3% -1.7% -8.0% 14.3% 9.9% -14.1% -14.12%
ROA 3Y Avg snapshot only -91.70%
ROIC Economic snapshot only -47.76%
Cash ROA snapshot only -6.18%
NOPAT Margin snapshot only -60.11%
Pretax Margin snapshot only -1.14%
R&D / Revenue snapshot only 1.06%
SGA / Revenue snapshot only 68.74%
SBC / Revenue snapshot only 6.26%
Valuation
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — -24.396
P/S Ratio — — — — — — — — — — — 40.846
P/B Ratio — — — — — — — — — — — 260.140
P/FCF — — — — — — — — — — — —
P/OCF — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — —
PEG Ratio snapshot only 0.504
Leverage & Solvency
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 4.14 2.84 0.89 1.20 0.34 1.99 1.66 1.46 2.70 2.88 4.67 4.671
Quick Ratio 4.14 2.84 0.89 1.20 0.33 1.99 1.66 1.46 2.70 2.88 4.67 4.671
Debt/Equity 4.86 -27.70 -3.55 -1.86 -1.36 -2.46 -1.44 -1.10 -3.59 -1.90 18.74 18.737
Net Debt/Equity -0.73 — — — — — — — — — -8.95 -8.946
Debt/Assets 0.68 0.82 1.07 1.48 1.97 1.25 1.60 1.01 0.65 0.78 0.53 0.531
Debt/EBITDA -4.18 -2.86 -2.23 -1.85 -2.72 -3.25 -2.31 -2.15 -2.23 -1.88 -1.84 -1.838
Net Debt/EBITDA 0.63 -0.53 -0.98 -1.30 -2.41 -1.87 -1.55 -0.75 0.50 -0.15 0.88 0.877
Interest Coverage — -18.71 -12.31 -5.37 -4.14 -3.12 -2.64 -3.33 -2.60 -2.90 -3.45 -3.448
Equity Multiplier 7.13 -33.66 -3.31 -1.26 -0.69 -1.96 -0.91 -1.09 -5.53 -2.43 35.27 35.266
Cash Ratio snapshot only 4.095
Debt Service Coverage snapshot only -2.801
Cash to Debt snapshot only 1.477
FCF to Debt snapshot only -0.144
Defensive Interval snapshot only 404.6 days
Efficiency & Turnover
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.08 0.12 0.21 0.46 0.30 0.37 0.51 0.52 0.61 0.65 0.65 0.652
Inventory Turnover — — — — 7.85 — — — 8.48 — — —
Receivables Turnover 5.71 16.20 11.43 13.39 9.39 15.72 13.52 20.75 20.68 16.57 24.36 24.357
Payables Turnover 0.00 -0.22 -0.03 0.59 0.91 3.16 2.60 1.40 0.85 4.20 4.44 4.442
DSO 64 23 32 27 39 23 27 18 18 22 15 15.0 days
DIO — — — 0 47 0 -1 0 43 0 -0 -0.3 days
DPO — — — 615 401 115 140 261 430 87 82 82.2 days
Cash Conversion Cycle — — — -587 -315 -92 -114 -244 -369 -65 -67 -67.5 days
Cash Velocity snapshot only 0.558
Capital Intensity snapshot only 2.284
Growth (YoY)
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue — — — — 1.8% 1.9% 1.3% 58.7% 1.6% 1.1% 1.3% 1.29%
Net Income — — — — -5.9% -1.7% -72.7% -23.7% 23.5% 3.6% 12.6% 12.63%
EPS — — — — -4.8% -1.4% -48.6% -6.9% 39.4% 18.8% 29.5% 29.49%
FCF — — — — -4.6% -1.4% -14.3% 92.3% 1.1% 1.1% 76.9% 76.91%
EBITDA — — — — -1.0% -23.3% -19.9% -5.8% -24.1% -59.2% -22.4% -22.45%
Op. Income — — — — -4.2% -1.1% -28.4% 15.6% 41.1% 38.9% 28.0% 28.01%
OCF Growth snapshot only 80.54%
Asset Growth snapshot only 1.92%
Debt Growth snapshot only -2.63%
Shares Change snapshot only 23.92%
Growth Quality
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.94 0.98 0.95 0.950
Earnings Stability — — — — — — — — 0.49 0.70 0.47 0.465
Margin Stability — — — — — — — — 0.88 0.73 0.80 0.797
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.91 0.99 0.95 0.949
Earnings Smoothness — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — —
Gross Margin Trend — — — — — — — — 0.02 -0.16 -0.10 -0.098
FCF Margin Trend — — — — — — — — 2.53 2.76 2.41 2.415
Sustainable Growth Rate — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 0.91 0.91 0.87 0.85 0.75 0.84 0.60 0.03 -0.12 -0.08 0.13 0.134
FCF/OCF 1.07 1.07 1.09 1.07 1.07 1.06 1.05 1.72 0.74 0.70 1.24 1.241
FCF/Net Income snapshot only 0.166
CapEx/Revenue 10.9% 18.2% 27.6% 19.3% 21.5% 14.1% 7.7% 5.7% 3.7% 2.9% 3.4% 3.40%
CapEx/Depreciation snapshot only 0.597
Accruals Ratio -0.01 -0.03 -0.09 -0.22 -0.31 -0.16 -0.56 -1.22 -0.81 -0.88 -0.60 -0.595
Sloan Accruals snapshot only 0.863
Cash Flow Adequacy snapshot only -4.147
Dividends & Buybacks
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.17 $0.00 $0.00 $0.00 $0.15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — 0.0% 0.0% — —
Total Payout Ratio — — — — — — — — — — — —
Div. Increase Streak — 0 — — — 0 — — — — — —
Chowder Number — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 1.00 0.89 0.89 0.89 1.02 1.05 1.08 1.12 0.98 0.96 0.92 0.925
Interest Burden (EBT/EBIT) 0.76 1.37 1.64 1.85 2.33 2.23 1.85 1.71 1.50 1.56 1.40 1.402
EBIT Margin -2.14 -2.47 -2.49 -1.88 -1.71 -1.18 -1.38 -1.26 -0.82 -0.84 -0.81 -0.813
Asset Turnover 0.08 0.12 0.21 0.46 0.30 0.37 0.51 0.52 0.61 0.65 0.65 0.652
Equity Multiplier 7.13 -33.66 -3.31 -1.26 -2.78 -3.85 -1.50 -1.14 -2.04 -2.22 -3.84 -3.840
Per Share
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.39 $-0.81 $-1.33 $-1.86 $-2.25 $-1.91 $-1.97 $-1.99 $-1.37 $-1.55 $-1.39 $-1.39
Book Value/Share $0.42 $-0.07 $-0.54 $-1.04 $-1.68 $-0.92 $-1.41 $-1.86 $-0.51 $-0.93 $0.09 $0.09
Tangible Book/Share $0.35 $-0.13 $-0.60 $-1.11 $-1.75 $-1.00 $-1.49 $-1.95 $-0.60 $-1.02 $-0.01 $-0.01
Revenue/Share $0.24 $0.27 $0.37 $0.60 $0.55 $0.69 $0.71 $0.83 $1.14 $1.24 $1.32 $0.54
FCF/Share $-0.38 $-0.79 $-1.26 $-1.70 $-1.80 $-1.70 $-1.24 $-0.11 $0.12 $0.09 $-0.23 $-0.72
OCF/Share $-0.36 $-0.74 $-1.16 $-1.58 $-1.68 $-1.61 $-1.18 $-0.07 $0.16 $0.12 $-0.19 $-0.70
Cash/Share $2.37 $1.48 $1.07 $0.56 $0.26 $0.96 $0.67 $1.34 $2.26 $1.62 $2.36 $2.36
EBITDA/Share $-0.49 $-0.64 $-0.85 $-1.04 $-0.84 $-0.70 $-0.88 $-0.95 $-0.83 $-0.94 $-0.87 $-0.87
Debt/Share $2.06 $1.82 $1.91 $1.93 $2.29 $2.27 $2.03 $2.05 $1.85 $1.76 $1.60 $1.60
Net Debt/Share $-0.31 $0.34 $0.84 $1.36 $2.03 $1.31 $1.36 $0.71 $-0.41 $0.14 $-0.76 $-0.76
Academic Models
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — —
Piotroski F-Score 2 2 2 2 2 2 4 6 7 6 6 6
Beneish M-Score — — — — -3.03 0.49 -3.97 -6.09 -2.77 -4.35 -2.90 -2.900
Ohlson O-Score snapshot only -2.520
Net-Net WC snapshot only $-0.23
Credit
Metric Trend Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BB
Credit Score 53.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 42.00 42.000
Credit Grade snapshot only 12
Credit Trend snapshot only 22.000
Implied Spread (bps) snapshot only 475.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms